Characterizing Deep Quality-of-Life Response in the TRuE-V1/TRuE-V2 Studies of Ruxolitinib Cream in Nonsegmental Vitiligo. (2026). SKIN The Journal of Cutaneous Medicine, 10(2), s752. https://doi.org/10.25251/bpnxm492